Bio-Gate AG
F:BIG1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bio-Gate AG
F:BIG1
|
DE |
|
E
|
EUROKAI GmbH & Co KgaA
F:EUK3
|
DE |
|
T
|
Take Off SpA
MIL:TKF
|
IT |
|
Fluicell AB
F:5J90
|
SE |
|
D
|
Decheng Technology AG
F:3330
|
DE |
|
P
|
Pressure Technologies PLC
F:PRS
|
UK |
|
C
|
Cebu Landmasters Inc
XPHS:CLI
|
PH |
|
P
|
Premier Products PCL
SET:PPP
|
TH |
|
B
|
Balfour Beatty PLC
OTC:BAFBF
|
UK |
|
J
|
JPI Healthcare Co Ltd
KOSDAQ:0010V0
|
KR |
|
T
|
Thai Coconut PCL
SET:COCOCO
|
TH |
|
B
|
Binh Dinh Pharmaceutical and Medical Equipment JSC
VN:DBD
|
VN |
|
K
|
KWG Group Holdings Ltd
OTC:KWGPF
|
CN |
|
A
|
Automatyka Pomiary Sterowanie SA
WSE:APS
|
PL |
|
A
|
Asiasoft Corporation PCL
SET:AS
|
TH |
|
T
|
Thai Plaspac PCL
SET:TPAC
|
TH |
|
Adagene Inc
NASDAQ:ADAG
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIG1's stock price target?
Not Available
BIG1 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Bio-Gate AG?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Bio-Gate AG?
Projected CAGR
13%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 13%.